Stock ScreenerStock IdeasStrong Financial HealthStrong Financial HealthA company's financial health is a key determinant of its ability to create shareholder value. Financials Rating puts significant emphasis on balance sheet strength and key financial stability indicators.
Stock ScreenerStock IdeasStrong Financial Health
Zen Rating: A + 1 more
Financials Rating: A + 1 more
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| EVR | EVERCORE INC | B | C | $10.58B | 39,605,448 | 78.82% | 21.18% | Net Selling | Net Selling |
| EVER | EVERQUOTE INC | A | B | $584.40M | 36,029,683 | 59.43% | 40.57% | Net Selling | Net Selling |
| TPR | TAPESTRY INC | B | B | $28.89B | 202,464,223 | 95.66% | 3.19% | Net Buying | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | C | $2.10B | 250,800,620 | 83.18% | 15.21% | Net Selling | Net Selling |
| DDS | DILLARD's INC | B | C | $8.96B | 15,612,966 | 24.84% | 75.16% | Net Buying | Net Buying |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.